Solid Biosciences
SLDB
124 hedge funds and large institutions have $292M invested in Solid Biosciences in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 15 closing their positions.
227% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 15
169% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 16
101% more capital invested
Capital invested by funds: $145M → $292M (+$146M)
38% more funds holding
Funds holding: 90 → 124 (+34)
10.83% more ownership
Funds ownership: 90.92% → 101.75% (+11%)
0% more call options, than puts
Call options by funds: $714K | Put options by funds: $714K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Commodore Capital
New York
|
+$24.9M |
| 2 |
PA
Perceptive Advisors
New York
|
+$21.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$21.3M |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$16.6M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$15.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VPC
Vestal Point Capital
New York
|
-$4.69M |
| 2 |
JP Morgan Chase
New York
|
-$4.02M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$1.02M |
| 4 |
Millennium Management
New York
|
-$793K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$661K |
SLDB Hedge Fund Activity: Q1 2025 in Review
124 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2025, worth a combined $292M — up 101% from $145M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new SLDB positions and 15 closed out — a net gain of 34 holders — while 43 added to existing stakes and 16 trimmed.
The largest buyer was Commodore Capital, opening a new position worth an estimated $24.9M. The largest seller was Vestal Point Capital, cutting an estimated $4.69M.
- 124 institutional investors held Solid Biosciences (SLDB) as of Q1 2025, up from 90 in Q4 2024.
- Funds reported $292M of Solid Biosciences stock for Q1 2025, up 101% quarter-over-quarter.
- 49 funds opened new Solid Biosciences positions in Q1 2025 and 15 closed out, a net change of +34 holders.
- The largest Solid Biosciences buyer in Q1 2025 was Commodore Capital, an estimated $24.9M added.
- The largest Solid Biosciences seller in Q1 2025 was Vestal Point Capital, an estimated $4.69M sold.
Based on aggregated 13F filings for Q1 2025.